nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—digestive system—colon cancer	0.0392	0.243	CbGeAlD
Icosapent ethyl—DGAT1—bone marrow—colon cancer	0.0361	0.224	CbGeAlD
Icosapent ethyl—DGAT1—vagina—colon cancer	0.0346	0.214	CbGeAlD
Icosapent ethyl—DGAT1—liver—colon cancer	0.0292	0.181	CbGeAlD
Icosapent ethyl—Facial paralysis—Vincristine—colon cancer	0.0235	0.0294	CcSEcCtD
Icosapent ethyl—DGAT1—lymph node—colon cancer	0.0224	0.139	CbGeAlD
Icosapent ethyl—Icosapent—PPARG—colon cancer	0.0194	0.51	CrCbGaD
Icosapent ethyl—VIIth nerve paralysis—Vincristine—colon cancer	0.0182	0.0228	CcSEcCtD
Icosapent ethyl—Facial paralysis—Capecitabine—colon cancer	0.0153	0.0192	CcSEcCtD
Icosapent ethyl—Peripheral vascular disorder—Irinotecan—colon cancer	0.0149	0.0186	CcSEcCtD
Icosapent ethyl—Sudden death—Irinotecan—colon cancer	0.0142	0.0178	CcSEcCtD
Icosapent ethyl—Sudden death—Fluorouracil—colon cancer	0.0136	0.017	CcSEcCtD
Icosapent ethyl—Enlargement abdomen—Irinotecan—colon cancer	0.0121	0.0151	CcSEcCtD
Icosapent ethyl—VIIth nerve paralysis—Capecitabine—colon cancer	0.0119	0.0149	CcSEcCtD
Icosapent ethyl—Intestinal obstruction—Vincristine—colon cancer	0.011	0.0137	CcSEcCtD
Icosapent ethyl—Intestinal obstruction—Irinotecan—colon cancer	0.0107	0.0134	CcSEcCtD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS2—colon cancer	0.0104	0.274	CrCbGaD
Icosapent ethyl—Proctalgia—Capecitabine—colon cancer	0.0104	0.013	CcSEcCtD
Icosapent ethyl—Sudden death—Capecitabine—colon cancer	0.00953	0.0119	CcSEcCtD
Icosapent ethyl—Myocardial ischaemia—Irinotecan—colon cancer	0.00907	0.0113	CcSEcCtD
Icosapent ethyl—Myocardial ischaemia—Fluorouracil—colon cancer	0.00868	0.0108	CcSEcCtD
Icosapent ethyl—Icosapent—PTGS2—colon cancer	0.0082	0.215	CrCbGaD
Icosapent ethyl—Cough increased—Irinotecan—colon cancer	0.00796	0.00994	CcSEcCtD
Icosapent ethyl—Intestinal obstruction—Capecitabine—colon cancer	0.00715	0.00894	CcSEcCtD
Icosapent ethyl—Sudden death—Methotrexate—colon cancer	0.00709	0.00886	CcSEcCtD
Icosapent ethyl—Colitis—Irinotecan—colon cancer	0.007	0.00874	CcSEcCtD
Icosapent ethyl—Laryngitis—Capecitabine—colon cancer	0.00677	0.00845	CcSEcCtD
Icosapent ethyl—Neoplasm—Irinotecan—colon cancer	0.00659	0.00823	CcSEcCtD
Icosapent ethyl—Fungal infection—Capecitabine—colon cancer	0.00632	0.00789	CcSEcCtD
Icosapent ethyl—Myocardial ischaemia—Capecitabine—colon cancer	0.00607	0.00758	CcSEcCtD
Icosapent ethyl—Polyp—Methotrexate—colon cancer	0.00597	0.00746	CcSEcCtD
Icosapent ethyl—Cyst—Methotrexate—colon cancer	0.00543	0.00678	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Vincristine—colon cancer	0.00516	0.00645	CcSEcCtD
Icosapent ethyl—Cataract—Capecitabine—colon cancer	0.00512	0.0064	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Irinotecan—colon cancer	0.00503	0.00628	CcSEcCtD
Icosapent ethyl—Neck pain—Capecitabine—colon cancer	0.00494	0.00617	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00489	0.00611	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Fluorouracil—colon cancer	0.00482	0.00602	CcSEcCtD
Icosapent ethyl—Melaena—Capecitabine—colon cancer	0.00476	0.00595	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00476	0.00595	CcSEcCtD
Icosapent ethyl—Fungal infection—Methotrexate—colon cancer	0.0047	0.00587	CcSEcCtD
Icosapent ethyl—Colitis—Capecitabine—colon cancer	0.00468	0.00585	CcSEcCtD
Icosapent ethyl—Fluid retention—Capecitabine—colon cancer	0.00463	0.00578	CcSEcCtD
Icosapent ethyl—Abdominal distension—Irinotecan—colon cancer	0.0046	0.00575	CcSEcCtD
Icosapent ethyl—Pancreatitis—Irinotecan—colon cancer	0.00448	0.0056	CcSEcCtD
Icosapent ethyl—Angina pectoris—Irinotecan—colon cancer	0.00445	0.00556	CcSEcCtD
Icosapent ethyl—Neoplasm—Capecitabine—colon cancer	0.00441	0.00551	CcSEcCtD
Icosapent ethyl—Dysphagia—Fluorouracil—colon cancer	0.00438	0.00547	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Vincristine—colon cancer	0.00432	0.0054	CcSEcCtD
Icosapent ethyl—Angina pectoris—Fluorouracil—colon cancer	0.00427	0.00533	CcSEcCtD
Icosapent ethyl—Pneumonia—Vincristine—colon cancer	0.00421	0.00526	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Vincristine—colon cancer	0.00413	0.00515	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Vincristine—colon cancer	0.0041	0.00513	CcSEcCtD
Icosapent ethyl—Pneumonia—Irinotecan—colon cancer	0.0041	0.00512	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Irinotecan—colon cancer	0.00402	0.00502	CcSEcCtD
Icosapent ethyl—Sweating—Vincristine—colon cancer	0.00401	0.00501	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Irinotecan—colon cancer	0.004	0.00499	CcSEcCtD
Icosapent ethyl—Gastroenteritis—Capecitabine—colon cancer	0.00399	0.00499	CcSEcCtD
Icosapent ethyl—Pneumonia—Fluorouracil—colon cancer	0.00393	0.00491	CcSEcCtD
Icosapent ethyl—Sweating—Irinotecan—colon cancer	0.00391	0.00488	CcSEcCtD
Icosapent ethyl—Infestation NOS—Fluorouracil—colon cancer	0.0039	0.00488	CcSEcCtD
Icosapent ethyl—Infestation—Fluorouracil—colon cancer	0.0039	0.00488	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Fluorouracil—colon cancer	0.00385	0.00481	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Fluorouracil—colon cancer	0.00383	0.00478	CcSEcCtD
Icosapent ethyl—Increased appetite—Capecitabine—colon cancer	0.00377	0.00471	CcSEcCtD
Icosapent ethyl—Epistaxis—Fluorouracil—colon cancer	0.00368	0.0046	CcSEcCtD
Icosapent ethyl—Rhinitis—Irinotecan—colon cancer	0.00367	0.00458	CcSEcCtD
Icosapent ethyl—Sinusitis—Fluorouracil—colon cancer	0.00366	0.00458	CcSEcCtD
Icosapent ethyl—Arthritis—Capecitabine—colon cancer	0.00364	0.00455	CcSEcCtD
Icosapent ethyl—Melaena—Methotrexate—colon cancer	0.00355	0.00443	CcSEcCtD
Icosapent ethyl—Rhinitis—Fluorouracil—colon cancer	0.00351	0.00439	CcSEcCtD
Icosapent ethyl—Migraine—Capecitabine—colon cancer	0.00348	0.00435	CcSEcCtD
Icosapent ethyl—Pharyngitis—Fluorouracil—colon cancer	0.00348	0.00435	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Capecitabine—colon cancer	0.00337	0.00421	CcSEcCtD
Icosapent ethyl—Mood swings—Capecitabine—colon cancer	0.00335	0.00419	CcSEcCtD
Icosapent ethyl—Alopecia—Vincristine—colon cancer	0.00332	0.00415	CcSEcCtD
Icosapent ethyl—Chills—Irinotecan—colon cancer	0.00328	0.0041	CcSEcCtD
Icosapent ethyl—Neoplasm—Methotrexate—colon cancer	0.00328	0.0041	CcSEcCtD
Icosapent ethyl—Arrhythmia—Irinotecan—colon cancer	0.00327	0.00408	CcSEcCtD
Icosapent ethyl—Alopecia—Irinotecan—colon cancer	0.00323	0.00404	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00319	0.00398	CcSEcCtD
Icosapent ethyl—Back pain—Vincristine—colon cancer	0.00316	0.00395	CcSEcCtD
Icosapent ethyl—Gastritis—Capecitabine—colon cancer	0.00313	0.00391	CcSEcCtD
Icosapent ethyl—Arrhythmia—Fluorouracil—colon cancer	0.00313	0.00391	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00312	0.0039	CcSEcCtD
Icosapent ethyl—Alopecia—Fluorouracil—colon cancer	0.0031	0.00387	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Methotrexate—colon cancer	0.00309	0.00386	CcSEcCtD
Icosapent ethyl—Back pain—Irinotecan—colon cancer	0.00308	0.00385	CcSEcCtD
Icosapent ethyl—Abdominal distension—Capecitabine—colon cancer	0.00308	0.00385	CcSEcCtD
Icosapent ethyl—Influenza—Capecitabine—colon cancer	0.00306	0.00382	CcSEcCtD
Icosapent ethyl—Asthma—Capecitabine—colon cancer	0.00306	0.00382	CcSEcCtD
Icosapent ethyl—Dysphagia—Capecitabine—colon cancer	0.00306	0.00382	CcSEcCtD
Icosapent ethyl—Angina pectoris—Capecitabine—colon cancer	0.00298	0.00372	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Irinotecan—colon cancer	0.00296	0.00369	CcSEcCtD
Icosapent ethyl—Bronchitis—Capecitabine—colon cancer	0.00294	0.00368	CcSEcCtD
Icosapent ethyl—Vertigo—Vincristine—colon cancer	0.00294	0.00367	CcSEcCtD
Icosapent ethyl—Malaise—Irinotecan—colon cancer	0.00287	0.00359	CcSEcCtD
Icosapent ethyl—Vertigo—Irinotecan—colon cancer	0.00286	0.00358	CcSEcCtD
Icosapent ethyl—Syncope—Irinotecan—colon cancer	0.00286	0.00357	CcSEcCtD
Icosapent ethyl—Hypertension—Vincristine—colon cancer	0.00282	0.00353	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Irinotecan—colon cancer	0.0028	0.0035	CcSEcCtD
Icosapent ethyl—Myalgia—Vincristine—colon cancer	0.00278	0.00348	CcSEcCtD
Icosapent ethyl—Cough—Irinotecan—colon cancer	0.00278	0.00347	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Capecitabine—colon cancer	0.00276	0.00345	CcSEcCtD
Icosapent ethyl—Hypertension—Irinotecan—colon cancer	0.00275	0.00344	CcSEcCtD
Icosapent ethyl—Pneumonia—Capecitabine—colon cancer	0.00274	0.00343	CcSEcCtD
Icosapent ethyl—Infestation NOS—Capecitabine—colon cancer	0.00273	0.00341	CcSEcCtD
Icosapent ethyl—Infestation—Capecitabine—colon cancer	0.00273	0.00341	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Capecitabine—colon cancer	0.00269	0.00336	CcSEcCtD
Icosapent ethyl—Discomfort—Irinotecan—colon cancer	0.00268	0.00335	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Capecitabine—colon cancer	0.00267	0.00334	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Vincristine—colon cancer	0.00267	0.00333	CcSEcCtD
Icosapent ethyl—Oedema—Vincristine—colon cancer	0.00267	0.00333	CcSEcCtD
Icosapent ethyl—Infection—Vincristine—colon cancer	0.00265	0.00331	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Irinotecan—colon cancer	0.0026	0.00325	CcSEcCtD
Icosapent ethyl—Oedema—Irinotecan—colon cancer	0.0026	0.00325	CcSEcCtD
Icosapent ethyl—Chest pain—Fluorouracil—colon cancer	0.0026	0.00324	CcSEcCtD
Icosapent ethyl—Myalgia—Fluorouracil—colon cancer	0.0026	0.00324	CcSEcCtD
Icosapent ethyl—Infection—Irinotecan—colon cancer	0.00258	0.00323	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Vincristine—colon cancer	0.00258	0.00322	CcSEcCtD
Icosapent ethyl—Epistaxis—Capecitabine—colon cancer	0.00257	0.00321	CcSEcCtD
Icosapent ethyl—Discomfort—Fluorouracil—colon cancer	0.00257	0.00321	CcSEcCtD
Icosapent ethyl—Shock—Irinotecan—colon cancer	0.00256	0.0032	CcSEcCtD
Icosapent ethyl—Anorexia—Vincristine—colon cancer	0.00254	0.00318	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Irinotecan—colon cancer	0.00251	0.00314	CcSEcCtD
Icosapent ethyl—Mood swings—Methotrexate—colon cancer	0.0025	0.00312	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Fluorouracil—colon cancer	0.00249	0.00311	CcSEcCtD
Icosapent ethyl—Oedema—Fluorouracil—colon cancer	0.00249	0.00311	CcSEcCtD
Icosapent ethyl—Anorexia—Irinotecan—colon cancer	0.00248	0.0031	CcSEcCtD
Icosapent ethyl—Infection—Fluorouracil—colon cancer	0.00247	0.00309	CcSEcCtD
Icosapent ethyl—Rhinitis—Capecitabine—colon cancer	0.00246	0.00307	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Vincristine—colon cancer	0.00243	0.00304	CcSEcCtD
Icosapent ethyl—Pharyngitis—Capecitabine—colon cancer	0.00243	0.00304	CcSEcCtD
Icosapent ethyl—Tachycardia—Fluorouracil—colon cancer	0.00243	0.00304	CcSEcCtD
Icosapent ethyl—Insomnia—Vincristine—colon cancer	0.00241	0.00302	CcSEcCtD
Icosapent ethyl—Anorexia—Fluorouracil—colon cancer	0.00237	0.00297	CcSEcCtD
Icosapent ethyl—Insomnia—Irinotecan—colon cancer	0.00235	0.00294	CcSEcCtD
Icosapent ethyl—Decreased appetite—Vincristine—colon cancer	0.00232	0.0029	CcSEcCtD
Icosapent ethyl—Dyspnoea—Irinotecan—colon cancer	0.00232	0.0029	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Vincristine—colon cancer	0.0023	0.00288	CcSEcCtD
Icosapent ethyl—Dyspepsia—Irinotecan—colon cancer	0.00229	0.00286	CcSEcCtD
Icosapent ethyl—Pain—Vincristine—colon cancer	0.00228	0.00285	CcSEcCtD
Icosapent ethyl—Constipation—Vincristine—colon cancer	0.00228	0.00285	CcSEcCtD
Icosapent ethyl—Asthma—Methotrexate—colon cancer	0.00228	0.00285	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00227	0.00283	CcSEcCtD
Icosapent ethyl—Decreased appetite—Irinotecan—colon cancer	0.00226	0.00282	CcSEcCtD
Icosapent ethyl—Insomnia—Fluorouracil—colon cancer	0.00225	0.00281	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Irinotecan—colon cancer	0.00224	0.0028	CcSEcCtD
Icosapent ethyl—Pancreatitis—Methotrexate—colon cancer	0.00223	0.00279	CcSEcCtD
Icosapent ethyl—Pain—Irinotecan—colon cancer	0.00222	0.00278	CcSEcCtD
Icosapent ethyl—Constipation—Irinotecan—colon cancer	0.00222	0.00278	CcSEcCtD
Icosapent ethyl—Dyspnoea—Fluorouracil—colon cancer	0.00222	0.00277	CcSEcCtD
Icosapent ethyl—Chills—Capecitabine—colon cancer	0.0022	0.00275	CcSEcCtD
Icosapent ethyl—Dyspepsia—Fluorouracil—colon cancer	0.00219	0.00274	CcSEcCtD
Icosapent ethyl—Arrhythmia—Capecitabine—colon cancer	0.00219	0.00273	CcSEcCtD
Icosapent ethyl—Decreased appetite—Fluorouracil—colon cancer	0.00216	0.0027	CcSEcCtD
Icosapent ethyl—Alopecia—Capecitabine—colon cancer	0.00216	0.0027	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00215	0.00269	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Irinotecan—colon cancer	0.00214	0.00268	CcSEcCtD
Icosapent ethyl—Malnutrition—Capecitabine—colon cancer	0.00213	0.00266	CcSEcCtD
Icosapent ethyl—Pain—Fluorouracil—colon cancer	0.00213	0.00266	CcSEcCtD
Icosapent ethyl—Body temperature increased—Vincristine—colon cancer	0.00211	0.00264	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Methotrexate—colon cancer	0.0021	0.00262	CcSEcCtD
Icosapent ethyl—Dysgeusia—Capecitabine—colon cancer	0.00209	0.00261	CcSEcCtD
Icosapent ethyl—Back pain—Capecitabine—colon cancer	0.00206	0.00258	CcSEcCtD
Icosapent ethyl—Body temperature increased—Irinotecan—colon cancer	0.00206	0.00257	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Fluorouracil—colon cancer	0.00205	0.00256	CcSEcCtD
Icosapent ethyl—Pneumonia—Methotrexate—colon cancer	0.00204	0.00255	CcSEcCtD
Icosapent ethyl—Infestation NOS—Methotrexate—colon cancer	0.00203	0.00254	CcSEcCtD
Icosapent ethyl—Infestation—Methotrexate—colon cancer	0.00203	0.00254	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Capecitabine—colon cancer	0.00198	0.00247	CcSEcCtD
Icosapent ethyl—Body temperature increased—Fluorouracil—colon cancer	0.00197	0.00246	CcSEcCtD
Icosapent ethyl—Sweating—Methotrexate—colon cancer	0.00195	0.00243	CcSEcCtD
Icosapent ethyl—Malaise—Capecitabine—colon cancer	0.00192	0.0024	CcSEcCtD
Icosapent ethyl—Epistaxis—Methotrexate—colon cancer	0.00192	0.00239	CcSEcCtD
Icosapent ethyl—Vertigo—Capecitabine—colon cancer	0.00192	0.00239	CcSEcCtD
Icosapent ethyl—Asthenia—Vincristine—colon cancer	0.00192	0.00239	CcSEcCtD
Icosapent ethyl—Syncope—Capecitabine—colon cancer	0.00191	0.00239	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Capecitabine—colon cancer	0.00187	0.00234	CcSEcCtD
Icosapent ethyl—Asthenia—Irinotecan—colon cancer	0.00187	0.00233	CcSEcCtD
Icosapent ethyl—Cough—Capecitabine—colon cancer	0.00186	0.00232	CcSEcCtD
Icosapent ethyl—Hypertension—Capecitabine—colon cancer	0.00184	0.0023	CcSEcCtD
Icosapent ethyl—Arthralgia—Capecitabine—colon cancer	0.00182	0.00227	CcSEcCtD
Icosapent ethyl—Myalgia—Capecitabine—colon cancer	0.00182	0.00227	CcSEcCtD
Icosapent ethyl—Chest pain—Capecitabine—colon cancer	0.00182	0.00227	CcSEcCtD
Icosapent ethyl—Pharyngitis—Methotrexate—colon cancer	0.00181	0.00226	CcSEcCtD
Icosapent ethyl—Discomfort—Capecitabine—colon cancer	0.00179	0.00224	CcSEcCtD
Icosapent ethyl—Dry mouth—Capecitabine—colon cancer	0.00178	0.00222	CcSEcCtD
Icosapent ethyl—Dizziness—Vincristine—colon cancer	0.00177	0.00221	CcSEcCtD
Icosapent ethyl—Pruritus—Fluorouracil—colon cancer	0.00176	0.0022	CcSEcCtD
Icosapent ethyl—Oedema—Capecitabine—colon cancer	0.00174	0.00217	CcSEcCtD
Icosapent ethyl—Infection—Capecitabine—colon cancer	0.00173	0.00216	CcSEcCtD
Icosapent ethyl—Dizziness—Irinotecan—colon cancer	0.00172	0.00215	CcSEcCtD
Icosapent ethyl—Shock—Capecitabine—colon cancer	0.00171	0.00214	CcSEcCtD
Icosapent ethyl—Tachycardia—Capecitabine—colon cancer	0.0017	0.00212	CcSEcCtD
Icosapent ethyl—Vomiting—Vincristine—colon cancer	0.0017	0.00212	CcSEcCtD
Icosapent ethyl—Rash—Vincristine—colon cancer	0.00168	0.0021	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Capecitabine—colon cancer	0.00168	0.0021	CcSEcCtD
Icosapent ethyl—Dermatitis—Vincristine—colon cancer	0.00168	0.0021	CcSEcCtD
Icosapent ethyl—Anorexia—Capecitabine—colon cancer	0.00166	0.00207	CcSEcCtD
Icosapent ethyl—Vomiting—Irinotecan—colon cancer	0.00165	0.00206	CcSEcCtD
Icosapent ethyl—Dizziness—Fluorouracil—colon cancer	0.00165	0.00206	CcSEcCtD
Icosapent ethyl—Rash—Irinotecan—colon cancer	0.00164	0.00205	CcSEcCtD
Icosapent ethyl—Dermatitis—Irinotecan—colon cancer	0.00164	0.00205	CcSEcCtD
Icosapent ethyl—Chills—Methotrexate—colon cancer	0.00164	0.00204	CcSEcCtD
Icosapent ethyl—Alopecia—Methotrexate—colon cancer	0.00161	0.00201	CcSEcCtD
Icosapent ethyl—Malnutrition—Methotrexate—colon cancer	0.00159	0.00198	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00159	0.00198	CcSEcCtD
Icosapent ethyl—Vomiting—Fluorouracil—colon cancer	0.00158	0.00198	CcSEcCtD
Icosapent ethyl—Insomnia—Capecitabine—colon cancer	0.00157	0.00197	CcSEcCtD
Icosapent ethyl—Rash—Fluorouracil—colon cancer	0.00157	0.00196	CcSEcCtD
Icosapent ethyl—Dermatitis—Fluorouracil—colon cancer	0.00157	0.00196	CcSEcCtD
Icosapent ethyl—Dysgeusia—Methotrexate—colon cancer	0.00155	0.00194	CcSEcCtD
Icosapent ethyl—Dyspnoea—Capecitabine—colon cancer	0.00155	0.00194	CcSEcCtD
Icosapent ethyl—Back pain—Methotrexate—colon cancer	0.00154	0.00192	CcSEcCtD
Icosapent ethyl—Dyspepsia—Capecitabine—colon cancer	0.00153	0.00191	CcSEcCtD
Icosapent ethyl—Decreased appetite—Capecitabine—colon cancer	0.00151	0.00189	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Capecitabine—colon cancer	0.0015	0.00188	CcSEcCtD
Icosapent ethyl—Pain—Capecitabine—colon cancer	0.00149	0.00186	CcSEcCtD
Icosapent ethyl—Constipation—Capecitabine—colon cancer	0.00149	0.00186	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Methotrexate—colon cancer	0.00147	0.00184	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Capecitabine—colon cancer	0.00143	0.00179	CcSEcCtD
Icosapent ethyl—Malaise—Methotrexate—colon cancer	0.00143	0.00179	CcSEcCtD
Icosapent ethyl—Vertigo—Methotrexate—colon cancer	0.00143	0.00178	CcSEcCtD
Icosapent ethyl—Cough—Methotrexate—colon cancer	0.00138	0.00173	CcSEcCtD
Icosapent ethyl—Body temperature increased—Capecitabine—colon cancer	0.00138	0.00172	CcSEcCtD
Icosapent ethyl—Chest pain—Methotrexate—colon cancer	0.00135	0.00169	CcSEcCtD
Icosapent ethyl—Myalgia—Methotrexate—colon cancer	0.00135	0.00169	CcSEcCtD
Icosapent ethyl—Arthralgia—Methotrexate—colon cancer	0.00135	0.00169	CcSEcCtD
Icosapent ethyl—Discomfort—Methotrexate—colon cancer	0.00134	0.00167	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Methotrexate—colon cancer	0.0013	0.00162	CcSEcCtD
Icosapent ethyl—Infection—Methotrexate—colon cancer	0.00129	0.00161	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Methotrexate—colon cancer	0.00125	0.00156	CcSEcCtD
Icosapent ethyl—Asthenia—Capecitabine—colon cancer	0.00125	0.00156	CcSEcCtD
Icosapent ethyl—Anorexia—Methotrexate—colon cancer	0.00123	0.00154	CcSEcCtD
Icosapent ethyl—Pruritus—Capecitabine—colon cancer	0.00123	0.00154	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00118	0.00147	CcSEcCtD
Icosapent ethyl—Insomnia—Methotrexate—colon cancer	0.00117	0.00146	CcSEcCtD
Icosapent ethyl—Dyspnoea—Methotrexate—colon cancer	0.00115	0.00144	CcSEcCtD
Icosapent ethyl—Dizziness—Capecitabine—colon cancer	0.00115	0.00144	CcSEcCtD
Icosapent ethyl—Dyspepsia—Methotrexate—colon cancer	0.00114	0.00142	CcSEcCtD
Icosapent ethyl—Decreased appetite—Methotrexate—colon cancer	0.00113	0.00141	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Methotrexate—colon cancer	0.00112	0.0014	CcSEcCtD
Icosapent ethyl—Pain—Methotrexate—colon cancer	0.00111	0.00138	CcSEcCtD
Icosapent ethyl—Vomiting—Capecitabine—colon cancer	0.00111	0.00138	CcSEcCtD
Icosapent ethyl—Rash—Capecitabine—colon cancer	0.0011	0.00137	CcSEcCtD
Icosapent ethyl—Dermatitis—Capecitabine—colon cancer	0.0011	0.00137	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Methotrexate—colon cancer	0.00107	0.00133	CcSEcCtD
Icosapent ethyl—Body temperature increased—Methotrexate—colon cancer	0.00102	0.00128	CcSEcCtD
Icosapent ethyl—Asthenia—Methotrexate—colon cancer	0.000929	0.00116	CcSEcCtD
Icosapent ethyl—Pruritus—Methotrexate—colon cancer	0.000916	0.00114	CcSEcCtD
Icosapent ethyl—Dizziness—Methotrexate—colon cancer	0.000857	0.00107	CcSEcCtD
Icosapent ethyl—Vomiting—Methotrexate—colon cancer	0.000824	0.00103	CcSEcCtD
Icosapent ethyl—Rash—Methotrexate—colon cancer	0.000817	0.00102	CcSEcCtD
Icosapent ethyl—Dermatitis—Methotrexate—colon cancer	0.000816	0.00102	CcSEcCtD
